Rebel Wilson has been on a health kick after over-indulging over Easter. The Australian actress, who dropped more than 36kgs ...

Novo Nordisk NVO shares have lost 16.7%, attributable to both sector-specific developments and broader macroeconomic ...

Lizzo, the singer and flutist behind Billboard chart-toppers like “Truth Hurts” and “About Damn Time,” has shared a lot with ...

Overall, Novo is expecting slower growth in 2025. The company is guiding for sales to rise between 16% and 24%, down from 26% ...

The virtual nutrition care startup just raised a $70 million Series B funding round, and it's profitable, BI has learned ...

Lizzo has revealed how she dropped a whopping 16% of her body fat during a TikTok livestream on Tuesday — months after publicly denying accusations that she used Ozempic. The “Truth Hurts” songstress, ...

Low-sugar, high-protein yoghurt Oikos has benefited from Danone's GLP-1 focus - Oikos. One in eight U.S. adults has now tried ...

Novo Nordisk's booming obesity drugs & diabetes portfolio make it a top growth play. Click here to read an analysis of NVO ...

Novo Nordisk (NYSE: NVO) stock hit an all-time high of $148.15 in June 2024, marking a remarkable fivefold surge since 2019.

Janet Jackson is climbing the charts once again with her early 2000s single 'Someone To Call My Lover'-- thanks to TikTok.

Shares of Novo Nordisk, the Danish pharmaceutical company behind the groundbreaking GLP-1 weight-loss drugs Ozempic and ...

Blockbuster weight loss drug Ozempic can cause a surprising side effect in your feet - and some celebrities are already ...